Guizhou Xinbang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Guizhou Xinbang Pharmaceutical has a total shareholder equity of CN¥7.1B and total debt of CN¥609.3M, which brings its debt-to-equity ratio to 8.6%. Its total assets and total liabilities are CN¥8.9B and CN¥1.8B respectively. Guizhou Xinbang Pharmaceutical's EBIT is CN¥297.1M making its interest coverage ratio 58.7. It has cash and short-term investments of CN¥752.3M.
Key information
8.6%
Debt to equity ratio
CN¥609.27m
Debt
| Interest coverage ratio | 58.7x |
| Cash | CN¥752.34m |
| Equity | CN¥7.10b |
| Total liabilities | CN¥1.80b |
| Total assets | CN¥8.90b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002390's short term assets (CN¥5.1B) exceed its short term liabilities (CN¥1.8B).
Long Term Liabilities: 002390's short term assets (CN¥5.1B) exceed its long term liabilities (CN¥40.8M).
Debt to Equity History and Analysis
Debt Level: 002390 has more cash than its total debt.
Reducing Debt: 002390's debt to equity ratio has reduced from 73.1% to 8.6% over the past 5 years.
Debt Coverage: 002390's debt is well covered by operating cash flow (80.8%).
Interest Coverage: 002390's interest payments on its debt are well covered by EBIT (58.7x coverage).